Navigation Links
CCBR-SYNARC Expands Electronic Data Capture Capabilities
Date:10/30/2009

SAN FRANCISCO, Oct. 30 /PRNewswire/ -- CCBR-SYNARC, the world's leading provider of medical image analysis, biochemical marker, and clinical research center services to the pharmaceutical and biotechnology industries, announced the expansion of its Electronic Data Capture ("EDC") capabilities for use in imaging clinical trials.

SYNARC has been using EDC to support global imaging trials since 2004. With the release of the enhanced SynarcConnect(SM) service, SYNARC has further improved its data and image transfer capabilities to meet the demanding standards of its in-house radiologists, scientific experts, and global sponsors.

"This latest release of our EDC system will improve the sponsor and investigator site experience in interacting with our service delivery teams," stated Herve Girsault, CEO. "As we constantly strive to achieve excellence in our service levels, I'm pleased with the results and reception of the enhanced SynarcConnect(SM) service."

The complexity of moving images and data from thousands of investigator sites across the globe to SYNARC's in-house readers is streamlined through the use of Web-based electronic data capture. Investigator sites only need access to the Internet to benefit from the electronic transmittal forms, study documents and electronic image transfer capabilities. Sponsors benefit from the decreased time between image acquisition and analysis, relief from costs associated with courier services, and efficient access to real-time study information via SynarcConnect(SM)'s Web-based reporting. Investigator sites also benefit from faster cycle times between image acquisition and centralized image quality review, resulting in improved protocol adherence and overall image quality.

About SYNARC

CCBR-SYNARC is the recognized world leader in medical image analysis, biochemical marker and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development.

SYNARC imaging services integrate critical aspects of clinical-trial design and execution, from protocol design to regulatory liaison on behalf of our clients. Our expert radiologists and scientists are innovators in all aspects of medical image analysis and have pioneered many methods used in today's clinical trials. Synarc has five imaging centers around the world providing global delivery capabilities in support of our clients' clinical development programs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091030/SF02009LOGO)

    Media Contact:
    Joy Valderrama
    415 817-8919
    joy.valderrama@synarc.com

www.synarc.com

SOURCE CCBR-SYNARC


'/>"/>
SOURCE CCBR-SYNARC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
2. Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
3. Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement
4. Hologic Expands Healthcare Investment in Asia
5. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
6. Raptor Pharmaceutical Expands Board of Directors
7. Intermountain McKay-Dee Hospital Center Expands Real-Time Locating Solution From Versus Technology, Inc.
8. Lupin Expands Branded Play
9. CEL-SCI Expands H1N1 Flu Virus Work
10. OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
11. Vision Inspection Systems Specialist Acquire Automation Expands Employee Base, Launches New Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):